Purpose: To evaluate the efficacy and toxicity of bortezomib with or without irinotecan, in patients with relapsed or refractory colorectal cancer (CRC).

• 目的：评估复发或耐药结直肠癌单用硼替佐米或联合伊立替康的疗效和毒副作用。